Evidence map›Paper›PMID 40971407›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2025

The potential impacts of human genetics on virus emergence.

Ryan A Langlois, Jean-Laurent Casanova

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Influenza.Nature reviews. Disease primers · 2026
    Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ryan A LangloisDepartment of Microbiology and Immunology, University of Minnesota, Minneapolis, MN 55455.ORCID 0000-0002-0515-571X
Jean-Laurent CasanovaSt. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY 10065.ORCID 0000-0002-7782-4169

Funding

Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational SuccessUL1TR001866 · NCATS · ROCKEFELLER UNIVERSITY · PI COLLER, BARRY, KRUEGER, JAMES G · 2016 to 2025
$40.6M
Study of the Cellular Basis of Herpes Simplex Encephalitis with hPSC-Derived CNS and PNS CellsR01NS072381 · NINDS · UT SOUTHWESTERN MEDICAL CENTER · PI Jean-Laurent Casanova, Shen-Ying Zhang · 2010 to 2026
$10.2M
Monogenic basis of resistance to SARS-CoV2 and predisposition to severe COVID-19R01AI088364 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI Jean-Laurent Casanova, Shen-Ying Zhang · 2010 to 2026
$8.7M
Inborn errors of immunity in patients with life-threatening COVID-19R01AI163029 · NIAID · ROCKEFELLER UNIVERSITY · PI CASANOVA, JEAN-LAURENT, ZHANG, QIAN · 2021 to 2025
$3.7M
Natural model for evaluating within- and cross-species virus transmissionR01AI173043 · NIAID · UNIVERSITY OF MINNESOTA · PI Ryan Langlois, Zhongde Wang · 2023 to 2026
$2.9M
Early Responses to Influenza A Virus Replication In VivoR01AI148669 · NIAID · UNIVERSITY OF MINNESOTA · PI LANGLOIS, RYAN · 2020 to 2024
$2.5M
New mouse model to better predict human immunity to influenza vaccination and infectionR01AI150600 · NIAID · UNIVERSITY OF MINNESOTA · PI LANGLOIS, RYAN, MASOPUST, DAVID · 2021 to 2024
$2.5M
Molecular and cellular basis of epidermodysplasia verruciformisR01AI143810 · NIAID · ROCKEFELLER UNIVERSITY · PI CASANOVA, JEAN-LAURENT, JOUANGUY, EMMANUELLE · 2020 to 2024
$2.0M
American Lung Association (ALA) COVID-1026207French Foundation for Medical Research EQU201903007798HHS | NIH | National Center for Advancing Translational Sciences (NCATS) UL1TR001866HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R01AI088364HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R01AI143810HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R01AI148669HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R01AI150600HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R01AI163029HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R01AI173043HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS) R01NS072381Howard Hughes Medical InstituteNCATS NIH HHS UL1 TR001866NIAID NIH HHS R01 AI088364NIAID NIH HHS R01 AI143810NIAID NIH HHS R01 AI148669NIAID NIH HHS R01 AI150600NIAID NIH HHS R01 AI163029NIAID NIH HHS R01 AI173043NINDS NIH HHS R01 NS072381
6 · The paper itself

Abstract

Human monogenic traits can confer resistance to viral infection in exposed individuals or predisposition to severe disease in infected individuals. Enhanced susceptibility can be driven directly by mutations in genes essential for control of the virus or indirectly via the production of autoantibodies against components of host defense. While the impact of viruses on individuals carrying these genotypes permitted their identification and has been amply studied, little is known about the impact of these human genotypes on the natural history of viruses, including not only persisting but also emerging viruses. We envisage several scenarios, including the possibility that genetically susceptible individuals serve as patient zeros, superspreaders, or mutation incubators, or that genetically resistant individuals even permit the selection of new viral mutants. Viruses are continually shared between individuals and even host species, where they can benefit from adaption to new environments. Current human viruses, as well as novel viruses from animal reservoirs, will continue to threaten the human population. Improvements in the scale of human genomic sequencing and analysis will permit testing hypotheses about the impact of human genetics on the origin and trajectory of viral infections, including future pandemics, which may ultimately help to prevent or curtail impending outbreaks.

Indexed as

Communicable Diseases, EmergingHuman GeneticsVirus DiseasesVirusesAnimalsGenetic Predisposition to DiseaseHumansMutationinborn errors of immunityinterferonvirus emergencevirus evolution

Identifiers

PMID40971407
PMCPMC12501139

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.